The overproduction of b-amyloid (Ab) fragments in transgenic APPswe/PS1dE9 mice results in formation of amyloid deposits in the cerebral cortex and hippocampus starting around four months of age and leading to cognitive impairment much later. We have previously found an age and transgenedependent weakening of muscarinic receptor-mediated transmission that was not present in young (6e10-week-old) animals but preceded both amyloid deposits and cognitive deficits. Now we investigated immediate and prolonged in vitro effects of non-aggregated Ab 1e42 on coupling of individual muscarinic receptor subtypes expressed in CHO (Chinese hamster ovary) cells and their underlying mechanisms. Immediate application of 1 mM Ab 1e42 had no effect on the binding of the muscarinic antagonist N-methylscopolamine or the agonist carbachol. In contrast, 4-day treatment of CHO cells expressing the M1 muscarinic receptor with 100 nM Ab 1e42 significantly changed the binding characteristics of the muscarinic agonist carbachol and reduced the extent of the M1 receptor-stimulated breakdown of phosphatidylinositol while it did not demonstrate overt toxic effects. The treatment had no influence on the expression of either G-proteins or muscarinic receptors. In concert, we found no change in the gene expression of muscarinic receptor subtypes and gene or protein expression of the G s , G q/11 , and G i/o G-proteins in the cerebral cortex of young adult APPswe/PS1dE9 mice that demonstrate high concentrations of soluble Ab 1e42 and impaired muscarinic receptor-mediated G-protein activation. Our results provide strong evidence that the initial injurious effects of Ab 1e42 on M1 muscarinic receptor-mediated transmissionis is due to compromised coupling of the receptor with G q/11 G-protein.
Introduction
Alzheimer's disease (AD) is presently the most widespread dementing neurodegenerative disease. A major hallmark of the disease is the presence of amyloid plaques and neurofibrilary tangles in the cerebral cortex and hippocampus. Studies of familial cases detected three genes directly linked to the disease and persuasively pointed to a crucial role of amyloid-b (Ab) fragments in the pathogenesis of the disease (Masters et al., 1985a,b; Hardy and Higgins, 1992; Selkoe, 2001) . A general consensus now exists that an increase in soluble Ab oligomers concentration initiates and drives the pathology of AD (McLean et al., 1999; Selkoe, 2002; Glabe, 2006) . However, the initial harmful functional effects that precede clinical manifestation, characteristic amyloid pathology, and neurodegeneration remain largely unknown. Consistent damage of cholinergic neurons in the basal forebrain in the terminal state of AD led to the formulation of the cholinergic hypothesis of AD (Bartus et al., 1982) . Despite doubts about the general applicability of this hypothesis (Davis et al., 1999; Bartus, 2000; DeKosky et al., 2002) , the responsiveness of the disease to cholinesterase inhibitor therapy supports its viability. It has been demonstrated that immunolesion of basal forebrain cholinergic neurons in rats resulting in presynaptic cholinergic deficit alters APP metabolism in cerebral cortex (Rossner et al., 1997) . In addition, treatment of Parkinson's patients with antimuscarinic drugs increases amyloid pathology (Perry et al., 2003) and M1 receptor gene knockout in mice increases amyloidogenic metabolism of APP (Davis et al., 2010) .
The development of transgenic mouse models of AD has enabled studies on deviations of neuronal functioning in the course of gradual in vivo increase in the concentration of soluble human Ab fragments and development of amyloid pathology. The APPswe/PS1dE9 transgenic mouse model of AD demonstrates a robust overproduction of Ab 1e42 fragments that finally leads to the appearance of amyloid pathology, cognitive decline, and neurodegeneration (Jankowsky et al., 2004; Savonenko et al., 2005; Liu et al., 2008) . In this model we have previously demonstrated age and transgene-dependent weakening of muscarinic receptor-mediated G-protein activation. This reduction was not present in young (6e10-week-old) mice but was already present at the time when amyloid plaques formation just started (Machova et al., 2008 (Machova et al., , 2010 .
In the present in vitro experiments we show that prolonged, but not immediate, treatment of Chinese hamster ovary (CHO) cells expressing individual muscarinic receptor subtypes with the Ab 1e 42 fragment specifically affects muscarinic M1 receptor/G-protein interaction. This damage manifests itself as a change in agonist binding characteristics and reduced efficacy in activating G q/11 Gprotein signaling. We next tested the hypothesis that reduction in muscarinic receptor-mediated signal transduction is due to changes in the expression of receptor/G-protein complex components. However, we found no changes in either gene expression of individual subtypes of muscarinic receptor or gene and protein expression of major subclasses of their preferential G-proteins in APPswe/PS1dE9 mice. In accordance, prolonged Ab 1e42 treatment of CHO cells expressing muscarinic receptor subtypes did not change membrane concentration of either G-proteins or muscarinic receptors. These findings support the notion that the early functional impairment of muscarinic transmission is likely due to a change that primarily occurs within the cell membrane and selectively impacts the M1 receptor/G-protein interaction.
Methods

Experimental animals
The APPswe/PS1dE9 founder mice were obtained from the Johns Hopkins University, Baltimore, MD, USA (D. Borchelt and J. Jankowsky, Dept. Pathology) and a colony was established at the University of Eastern Finland at Kuopio Finland as described previously (Machova et al., 2008) . The housing conditions (LaboratoryAnimal Center, Kuopio, Finland and Animal Facility of the Institute of Physiology, v.v.i. in Prague, Czech Republic) were controlled (temperature 22 C, light from 07:00 to 19:00; humidity 50e60%), and fresh food and water were freely available. Female transgenic mice and littermate controls were transported to Prague by air and left to adapt for at least two weeks before experiments. Two age groups of mice were used, young (7e10 weeks) and adult (5e7 months). The experiments were conducted according to the Council of Europe (Directive 86/609) in accordance with the Declaration of Helsinki.
Cell cultures and preparation of membranes
Cell culturing and membrane preparation were done essentially as described earlier (Jakubik et al., 2006) . Briefly, Chinese hamster ovary cells stably transfected with the human M1 through M5 muscarinic receptor genes (kindly supplied by Prof. T.I. Bonner) were grown to confluency in 75 cm 2 flasks in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 0.01% geneticine to confluency. Then they were subcultured to sixteen 100-mm Petri dishes. For experiments on prolonged effects, 100 nM human amyloid b 1e42 (Ab 1e42; US Peptides, Rancho Cucamonga, CA) was added to medium next day after subculturing. Stock solution of Ab 1e42 was prepared in redestilled water and stored in aliquots at À20 C. Cells were grown in a CO 2 incubator for 5 days without change of medium (four days in the presence of Ab 1e42 ) and then harvested. For experiments on immediate effects of Ab 1e42 during binding assay, 5 mM sodium butyrate was added to the culture medium one day before harvesting to increase receptor expression (levels of receptor expression are shown in Supplementary material Table S2 ). Incubation medium was removed; cells were washed with 10 ml of phosphatebuffered saline (PBS), mechanically released into 5 ml of fresh PBS, and collected by 3-min centrifugation at 1000 Â g. Washed cells were diluted in ice-cold homogenization medium (100 mM NaCl, 20 mM Na-HEPES buffer, and 10 mM EDTA, pH 7.4) and homogenized on ice by two 30-s strokes in Ultra-Turrax homogenizer (Janke and Kunkel, Germany) with a 30 s pause between strokes. Cell homogenate was first centrifuged for 3 min at 300 g to remove coarse cell debris and nuclei. The crude membrane fraction was sedimented for 30 min at 30 000 g at 4 C. The pellet was resuspended in incubation medium (100 mM NaCl, and 20 mM Na-HEPES buffer, pH 7.4), and centrifuged again under the same conditions. Pellets were kept at À75 C until assayed for no more than 12 weeks. Membrane protein content was determined using Peterson's modification of Lowry's method (Lowry et al., 1951; Peterson, 1977) with human serum albumin as a standard.
2.3. mRNA expression of muscarinic receptor subtypes and G-proteins a-subunits
Total RNA from about 20 mg of cerebral cortices of 6e10 weeks and 5e6 months old APPswe/PS1dE9 female mice was isolated using RNAwiz (Ambion, UK) and further processed using DNA-free kit (Ambion, UK). The purity was checked spectrophotometrically at 260 nm and 280 nm. Reverse transcription of isolated RNA was performed using M-MLV RT (Promega, USA) in accordance with the manufacturer's instructions in a final volume of 10 ml with 1 mg of isolated RNA and 1 mg of anchored oligo(dT)23 primers (Sigma, Prague). Primers are listed in Supplementary material (Table S1 ). Quantification of mRNA was done essentially as described (Machova et al., 2009 ) using Light Cycler (Roche, USA) and Light Cycler software. Denaturation analysis was performed to verify the identity of the product. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal standard.
Western blot and immunodetection of G-protein a-subunits
Separation and detection of membrane proteins was done essentially as described (Rudajev et al., 2005) . Briefly, membranes (40 mg of proteins) were dissolved in sodium dodecylsulphate and separated on 13% polyacrylamide gels. Separated proteins were transferred to nitrocellulose membrane and visualized using primary antibodies (from Santa Cruz Biotechnology, USA) and secondary HRPlabeled antibodies and ECL kit (from Pierce, USA). H-NMS; GE Healthcare, UK) as described previously (Michal et al., 2009 ). Affinity of the agonist carbachol was estimated in displacement experiments using 1 nM 3 H-NMS as a tracer. Non-specific binding was determined in the presence of 10 mM atropine. Fast filtration to separate bound and free ligand was carried out using Unifilter plates (Whatman, USA) and Brandel Harvestor (Brandel, USA). Plates were dried in vacuum and radioactivity retained on filters was determined in Rotiszint (Carl Roth, Germany) using Microbeta scintillation counter (PerkinElmer Wallac, Finland).
Saturation and displacement binding studies
GTP-g 35 S binding
Muscarinic receptor-induced activation of G-proteins was determined as an increase of GTP-g 35 S binding to membranes induced by the muscarinic receptor agonist carbachol, essentially as described earlier (Jakubik et al., 2006; Machova et al., 2008) . Briefly, 50 ml aliquots of membranes containing 5e20 mg protein were first incubated for 15 min at 30 C in 150 ml of reaction buffer containing 100 mM NaCl, 10 mM MgCl 2 , 20 mM HEPES, 1 mM DTT, 40 mM GDP for M2 and M4 receptors or 1 mM GDP for M1 and M3 receptors, and the non-hydrolyzable acetylcholine analog carbachol at a concentration range 0.15e1000 mM for M1 and M3 receptors or 0.02e100 mM for M2 and M4 receptors. Afterward 50 ml aliquots of GTP-g 35 S (Biotrend Chemikalien, Germany; SRA 1000 Ci/mmol) were added to give a final concentration of 500 pM and incubation continued for another 20 min. Total content of G-proteins in membranes was determined as GTP-g 35 S binding in the absence of GDP. Non-specific binding was assessed in the presence of 10 mM unlabeled GTP. Incubation was terminated by rapid vacuum filtration through Whatman GF/F filters using Tomtec Harvester Mach III (USA). Radioactivity retained on filters was measured with Wallac Microbeta counter.
Functional assays in intact cells
Inositol phosphates accumulation induced by carbachol was assayed in attached cells expressing M1 receptor grown in 24-well-plates essentially as described previously (Michal et al., 2009) . Cells were loaded with 3 H-myo-inositol (ARC, USA)
for 3 h, free 3 H-myo-inositol was washed off, and the carbachol-induced 3 H-inositolphosphates accumulation was measured in medium containing 10 mM lithium and respective concentrations of carbachol (0e100 mM) after 5 min lasting incubation at 37 C. Inhibition of forskolin-stimulated cAMP synthesis was measured in M2 receptor expressing cell suspension in DMEM saturated with 5% CO 2 /95% O 2 .
Cells from one 10 cm diameter Petri dish were mechanically released to phosphatebuffered saline, separated by careful repeated aspiration to a pipette, sedimented at 200 Â g for 5 min, and supernatant was discarded. The cell pellet was resuspended in 4 ml DMEM containing 1 mM isobutylmethylxanthine (IBMX) and preincubated for 5 min at room temperature. One hundred ml aliquots of cell suspension (approximately 100 mg of proteins) were transferred to prewarmed 100 ml aliquots of DMEM containing forskolin and relevant concentrations of carbachol (final concentrations during incubation were 100 mM for IBMX, 10 mM for forskolin and 0e 10 mM for carbachol). Incubation for 10 min at 37 C was stopped by transferring samples on ice and adding HCl to a final 100 mM concentration. Aliquots (100 ml) of HCl extracts were taken for cAMP determination using Elisa kit (New East Biosciences, USA) according to instructions of the manufacturer. Influence of prolonged Ab 1e42 treatment on the formation of reactive oxygen intermediates in cells grown in 24-well-plates was determined using the fluorescence probe 6-carboxy-2 0 ,7 0 -dichlorodihydrofluorescein diacetate (Molecular Probes, USA) as described earlier (Novakova et al., 2005) .
Activities of caspase-3 and caspase-8
Activities of caspase-3 and caspase-8 were determined in cell lysates prepared from cells grown in 24-well-plates fluorometrically using acDVED-AMC and acIETD-AMC substrates (Sigma, Prague) as described earlier (Novakova et al., 2005) .
Determination of Ab 1e42 aggregation
The extent of Ab 1e42 aggregation in stock solution (at the beginning of cultivation) and in cultivation medium after 4-day incubations was determined using thioflavineT binding and Western blot. Thioflavine binding was estimated in microtitration plates as described by Betts et al. (2008) . One hundred microlitre aliquots of samples were mixed with 100 ml of 200 mM glycine buffer (pH 8.5) containing 12 mM thioflavine T (Sigma Aldrich, Czech Republic). The fluorescence at 485 nm after excitation at 435 nm was determined by plate reader VictorÔ (Perkin Elmer). Western blot and immunodetection was done after separation on 4e20% gradient polyacrylamide gel. Separated samples were transferred to nitrocellulose membrane and assemblies of Ab 1e42 were visualized using primary antibodies 4G8 and 6E10 (from Covance, USA) and secondary HRP-labeled antibodies and ECL kit (from Pierce, USA). For electron microscopy, five ul drops of Ab 1e42 stock solution (100 mM in water) were applied onto glow-discharge activated carbon-coated grids (Benada and Pokorny, 1990) and let adsorb for 30 s. The grids were then washed with 1% ammonium molybdate and immediately negatively stained with 2% uranyl acetate in double distilled water for 30 s. The excess of water was blotted with filter paper and the grids were air-dried. The samples were examined in a Philips CM100 electron microscope at 80 kV. The images were digitally recorded using MegaViewII slow scan camera at 64 000 times magnification, which gives pixel size of about 1 nm.
Data treatment and statistical evaluation
Curve fitting and statistical evaluation of data was done using Prism 5 (GraphPad Software Inc., CA, USA). Rectangular hyperbolae were fitted to data obtained in saturation analysis experiments. A sigmoidal concentrationeresponse curve equation with constant or variable slope as appropriate was fitted to data obtained in GTP-g 35 S binding, inositolphosphates accumulation, and cAMP inhibition experiments. A two-sites displacement curve equation was fitted to data obtained in displacement experiments. Better fits were determined using F-test. The significance of differences among groups was tested by Anova and indicated post-hoc tests, t-test, or paired t-test as appropriate. Results are shown as means AE S.E.M. 
Functional consequences of prolonged Ab 1e42 treatment
In subsequent experiments we probed muscarinic receptormediated G-protein activation as carbachol-induced GTP-g 35 S binding in membranes prepared from cells subjected to prolonged treatment with 100 nM Ab 1e42 . This treatment did not change either basal (in the absence of agonist) or total (in the absence of GDP in the reaction mixture) binding of GTP-g 35 S at any receptor subtype (see Supplementary material; Table S3 ). Similarly, prolonged Ab 1e42 treatment had no effect on the concentrationeresponse curves of receptor activation at any of the M1 through M4 receptor subtypes (Fig. 2 , Table 2A ). However, all curves displayed Hill slopes significantly smaller than unity, indicating interactions of muscarinic receptor subtypes with more than one G-protein over the applied concentration range of carbachol.
To test more closely for a possible influence of the treatment on M1 receptor signaling pathways, we determined M1 receptorstimulated inositolphosphates accumulation that is mediated by M1 preferential G q/11 G-proteins in intact CHO cells. M2 receptormediated inhibition of forskolin-stimulated cAMP synthesis that is mediated by G i/o G-proteins served as a negative control. As shown in Fig. 3 and Table 2B , prolonged treatment with 100 nM Ab 1e42 reduced the efficacy of M1 receptor-mediated inositolphosphates accumulation by about 14% (p < 0.01 by paired t-test, five independent experiments in triplicates) while M2 receptormediated inhibition of forskolin-stimulated cAMP synthesis remained intact (six independent experiments in triplicates).
Attenuation of phosphatidylinositol hydrolysis was not due to changes in membrane concentrations of labeled phosphatidylinositol (see text to Fig. 3) . Similarly, the density of muscarinic receptor subtypes (see Supplementary material Table S2 ) or their preferential G-proteins (Fig. 4) was not changed by the treatment. Another possible explanation for the observed effects of prolonged treatment with 100 nM Ab 1e42 on attenuation of M1 receptor signaling is potential general noxious effects of Ab 1e42 (Yankner, 1996; Yankner and Lu, 2009) . This is unlikely, however, because four-day treatment of CHO cells with Ab 1e42 up to 1 mM concentration had no effect on either caspase-3 or caspase-8 activity ( Fig. 5A and B, respectively) , while 10 mM Ab 1e42 significantly induced caspase-3 activity. Similarly, an increase in formation of reactive oxygen intermediates in intact cells became apparent only at Ab 1e42 concentration of 1 mM and above (Fig. 5C ).
Determination of Ab 1e42 species in cultivation medium
In the next experiments we determined which molecular forms of Ab 1e42 are present in cultivation media after four days of treatment. As is shown in Fig. 6 , using Western blot and immunodetection, two different antibodies detected low molecular mass oligomers both in stock solution of Ab 1e42 and in media after 4-day incubation of Ab 1e42 treated CHO cells in culture. We further verified this finding with the help of thioflavine binding (Fig. 7) . The aggregation of 100 mM stock solution of Ab 1e42 in 10 mM HCl for 24 h at 37 C followed by centrifugation at 16 000 g (Stine et al., 2003) yielded aggregated amyloid that contained 44% of original peptide in stock solution. Measurements of serial dilutions of aggregated amyloid dispersed in supplemented DMEM displayed a linear relationship between peptide concentration and fluorescence signal, and a detection limit between 33 and 100 ng (Fig. 7B) . The soluble (16 000 g supernatant) amyloid as well as the original stock solution in water showed only small aggregation signal that became significant at concentrations ranging from 128 mg/ml (211 ng of thioflavine-positive species, i.e. 1.6%) and 26 mg/ml (138 ng of thioflavine-positive species at a concentration of 104 mg/ml, i.e.
1.2%), respectively. In concert with thioflavine binding, electron microscopy analysis of 100 mM Ab 1e42 stock solution showed no amyloid aggregates and only sporadic fibrils (Fig. 7C) . After 4-day incubation of CHO cells in the presence of increasing concentrations of Ab 1e42 we found significant fluorescence signal only in medium containing 10 mM Ab 1e42 (98 ng of thioflavine-positive species, i.e. 2.2%). We did not detect any signal in media with 0.1e 1 mM Ab 1e42 after four days in culture (Fig. 7A) .
Muscarinic receptors and G-proteins expression in transgenic animals
Finally we investigated if gradual in vivo accumulation of soluble Ab 1e42 influences muscarinic receptor and G-proteins expression. The mRNA concentration of M1 through M4 muscarinic receptor subtypes did not differ between wild-type littermate control and transgenic APPswe/PS1dE9 female mice in the cerebral cortex of both 6e10-week-old (young) and 5e7-month-old (young adult) mice. The expression of the M5 subtype mRNA was under the detection limit in both age groups. Expression of the M1 muscarinic receptor, the most abundant subtype, represented similar proportions of all subtypes in young and young adult animals (51% and 62%, respectively). However, the rank order of abundance of muscarinic receptor subtypes changed from M1 > M4 > M2 > M3 Table S3. in young to M1 > M2 > M4 > M3 in young adult animals ( Fig. 8A and B).
Similar to muscarinic receptor subtypes, the mRNA expression of the a-subunits of both inhibitory ( Fig. 8C and D) and stimulatory ( Fig. 8E and F) G-proteins was the same in wild-type and transgenic animals in both age groups. The rank order of abundance of stimulatory G-protein a-subunits was G 11 > G q > G s in both young and young adult animals, whereas that of inibitory G-protein a-subunits changed from Gi2 > Go > Gi1 > Gi3 in young mice to Gi1 > Gi3 > Go > Gi2 in young adult mice. Because we have earlier observed a decrease in the potency of muscarinic receptormediated G-protein activation in transgenic mice starting at the age of 5e6 months (Machova et al., 2008 (Machova et al., , 2010 , we also determined protein expression of a-subunits of major G-protein classes in cortical membranes. None of the major G-protein classes or the protein levels of the house-keeping gene Na/K-ATPase differed between wild-type and transgenic animals at the age of 5e6 months (see Supplementary material Fig. S1 ).
Discussion
Despite decades of intensive research, the exact role of cholinergic neurotransmission in the pathogenesis of Alzheimer's disease (AD; Bartus et al., 1982 ) is still unclear. General malfunction of postsynaptic cholinergic mechanisms in post mortem AD brain samples (Roth et al., 1995; Greenwood et al., 1995; Jope et al., 1994 Jope et al., , 1997 Shiozaki and Iseki, 2004) , as well as correlation of impaired muscarinic M1 receptor/G-protein coupling with disease severity (Tsang et al., 2005) are in favor of an involvement of impairment of muscarinic signaling. However, all these findings relate to the advanced or end-state of the disease, which makes it difficult to discern whether deficits in cholinergic transmission also play a significant role in the early pathogenesis. Since such studies are difficult to carry out in humans, we employed a transgenic mouse model of AD to probe integrity of cholinergic transmission during aging and amyloid accumulation. We found an early reduction of muscarinic receptor-mediated activation of G-proteins that was not present in young transgenic animals and developed parallel to a gradual increase in the concentration of soluble human Ab fragments (Machova et al., 2008 (Machova et al., , 2010 .
The present experiments investigated whether in vitro application of non-mutated human Ab 1e42 influence signal transduction Hmyo-inositol, and concentrationeresponse curves for stimulation by carbachol (abscissa, log M) were determined. The carbachol-induced increase in IP's accumulation is expressed as net increase in percent of loaded radioactivity (ordinate). The treatment with Ab 1e42 had no effect either on inositol loading (132 AE 5 and 141 AE 6 dpm/mg of protein) or basal accumulation of inositolphosphates (25.4 AE 1.8 and 24.4 AE 1.0 percent of loaded radioactivity in control and treated cells, respectively; mean AE S.E.M. from five independent experiments). B: Cells were incubated in medium containing phosphodiesterase inhibitor and forskolin to stimulate cAMP synthesis, and the concentrationeresponse curves of cAMP synthesis inhibition by carbachol (abscissa, log M) were determined as described in Methods. The inhibition of forskolin-stimulated cAMP synthesis during incubations is expressed in percent of control (ordinate). Treatment with Ab 1e42 had no effect on forskolin-stimulated synthesis of cAMP in the absence of carbachol (478 AE 50 and 488 AE 61 pmol/ mg protein/10 min in control and Ab 1e42 treated cells, respectively). The sigmoidal three parameter concentrationeresponse equation was fitted to data in both graphs. Parameters of fits are shown in Table 2. across plasma membrane in CHO cells expressing muscarinic receptor subtypes in isolation. The muscarinic receptor family comprises five subtypes (Bonner, 1989; Buckley et al., 1989) of which M2 and M4 receptors preferentially signal through G i/o G-proteins, while M1, M3, and M5 subtypes preferentially employ G q/11 G-proteins (Jones et al., 1988; Jones, 1993) . We found a selective impairment of M1 receptor/G q/11 G-protein coupling after 4-day treatment of cells with relatively low (100 nM) concentration of Ab 1e42 . This detrimental effect was not due to a general Ab 1e42 toxicity, because consistent with results in neuronal cell lines (Huang et al., 1998; Novakova et al., 2005) and primary neurons (Huang et al., 2000) , we observed commonly described toxic effects like increased reactive oxygen species or caspase-3 activity only at concentrations 10e100 times higher. In concert, we did not observe morphological abnormalities in either living cells using phase contrast microscopy or nuclear staining of fixed cells (see Supplementary material Fig. 2S) . We found only a small proportion of amyloid aggregates in stock solution we used, and detectable thioflavine binding only after 4-day incubation of cells in 10 mM Ab 1e42 . Our results thus support the view that overt cellular toxicity requires higher concentrations of Ab 1e42 to allow formation of amyloid aggregates.
The abnormal M1 receptor agonist binding after Ab 1e42 treatment at 100 nM manifested itself as increased proportion of high- affinity binding sites, accompanied by decreased binding affinity. In contrast, ten times higher concentrations of Ab 1e42 had no direct effect on the binding characteristics of either the muscarinic antagonist N-methylscopolamine or the agonist carbachol. Increased proportion of high-affinity binding sites were found to a lesser extent also at M3 receptors but not at the remaining muscarinic receptor subtypes, including the G q/11 G-protein preferring M5 subtype. Low-affinity agonist binding was not changed at any subtype. Uncoupling of M1 receptors using a nonhydrolyzable analog of GTP shifted the two-site carbachol binding curves to the same affinity single-site low-affinity binding curve irrespective of Ab 1e42 treatment. Agonists bind with low-affinity to free receptors, uncoupled from G-proteins. The lack of Ab 1e42 treatment effect on low-affinity binding further indicates the absence of a direct interaction of Ab 1e42 with the M1 receptor. The high-affinity agonist binding conformation is due to allosteric interactions of carbachol and the complex of receptor with free or GDP-liganded G-protein (Abdulaev et al., 2006; Jakubik et al., 2011) . The decrease in affinity and increase in proportion of high-affinity binding sites evidence that prolonged treatment with Ab 1e42 impacts interactions between the receptor and G-protein within the plasma membrane, downstream of agonist binding. Despite influencing agonist binding at M1 receptor, the treatment had no influence on muscarinic receptor-mediated stimulation of GTP-gS binding. However, carbachol-stimulated GTP-gS binding displayed a flat concentrationeresponse curve (Hill slope significantly less than unity), indicating activation of more than one class of G-proteins (Tucek et al., 2002; Michal et al., 2007; Jakubik et al., 2006 Jakubik et al., , 2011 . This complicates accurate detection of the presumed impairment of M1 receptor-mediated G q/11 G-protein activation deduced from increased GTP-gS binding in membranes. Nonetheless, the observed decrease in carbachol-stimulated inositolphosphates accumulation supports the view of impaired M1 receptor coupling with G q/11 G-proteins. The selectivity of prolonged Ab 1e42 treatment in impairing G q/11 G-protein signaling was also supported by the observation of unimpaired M2 receptor/G i/o G-protein-mediated inhibition of cAMP accumulation in intact cells, in agreement with intact G i/o G-protein-mediated autoinhibition of acetylcholine release in cortical slices from transgenic mice (Machova et al., 2010) . The specific effect of Ab on M1 receptor coupling is further evidenced by the differential influence on the binding characteristics at other receptor subtypes and the lack of effect of the scrambled peptide on the M1 receptor.
A conceivable explanation for the compromised muscarinic receptor signaling would be a reduced membrane concentration of G-proteins that are an integral part of the signal transduction apparatus. However, a prolonged Ab 1e42 treatment of CHO cells did not change membrane concentration of G-proteins. Similarly, in line with current literature on human brain (McLaughlin et al., 1991; Jope et al., 1994; Wang and Friedman, 1994; Greenwood et al., 1995; Muma et al., 2003; Hashimoto et al., 2004) , we found no changes in membrane G-protein concentrations or gene expression of major G-protein classes in the cerebral cortex of 5e6-month-old transgenic APPswe/PS1dE9 mice that at this age already demonstrate a significant attenuation of muscarinic receptormediated G-protein activation (Machova et al., 2008) .
Disorders of many G-protein coupled receptors are habitually found at autopsy in verified AD, which points to their contribution to AD pathogenesis (for review see Thathiah and De Strooper, 2011 ). An interesting explanation of impaired receptor/G-proteinmediated signaling in transgenic mouse models of AD is G q/11 Gprotein buffering by oligomerized angiotensin AT2 receptors (AbdAlla et al., 2009a,b) . This potential mechanism, however, does not seem to explain our findings, because the prolonged treatment with 100 nM Ab 1e42 did not induce oxidative stress that triggers A B C Fig. 6 . Western blot determination of Ab 1e42 species in stock solutions and incubation media after four days of incubation. A: Samples of A b1e42 in water stock solution (lines 1e3: 2000 ng, 400 ng, and 80 ng in 15 ml of water, respectively) and in incubation media after four days in culture (lines 4e7: 0 ng/15 ml, 6.75 ng/15 ml, 67.5 ng/15 ml, 67.5 ng/1.5 ml of incubation medium, respectively) were separated on gradient 4e20% polyacrylamide gel, transferred to nitrocellulose membrane, and visualized using 4G8 antibody. Shown immunoblot includes bottom of wells to check for presence of amyloid that did not enter the gel. B and C: Samples of Ab 1e42 in stock solution (lines 1e3: 50 ng, 100 ng, and 50 ng from another stock solution in 15 ml of water, respectively) and in incubation media after four days in culture (lines 4e7: 0 ng/15 ml, 6.75 ng/15 ml, 67.5 ng/15 ml, and 90 ng/2 ml of incubation medium, respectively) were separated as above and visualized using 4G8 (B) or 6E10 (C) antibody.
receptor oligomerization, and in addition, CHO cells do not express AT2-receptors (Feng et al., 2005) . Dysregulation of the signaling pathway activated by G q/11 G-proteins have been suggested to play a role in AD (for review see Bothmer and Jolles, 1994; Fowler et al., 1996) . Non-toxic concentrations of Ab fragments in vitro have been shown to affect distant targets like inositolphosphate receptors (Cowburn et al., 1995; Kurumatani et al., 1998) , intracellular calcium levels (Huang et al., 1998) , inositol(1,4,5)-trisphosphate-5-phosphatase activity (Ronnback and Fowler, 2000) or choline transport via protein kinase C pathway (Novakova et al., 2005) . A direct effect of Ab fragments on tachykinine receptor and synergy of its activation with glutamate signaling has also been demonstrated (Kimura and Schubert, 1993) . In binding and functional experiments we investigated the interaction of muscarinic receptors with G-protein and the formation of second messengers by enzymes incorporated in the cell membrane. The observed reduction of phosphatidylinositol hydrolysis could have derived from decreased availability of the labeled substrate. This seems unlikely, however, because Ab 1e42 had no effect on the labeling of cells with myoinositol. A direct inhibition of phospholipase C activity is also an unlikely explanation, since we found no difference in the basal inositolphosphates accumulation between control and treated cells as we would expect in case of phospholipase C inhibition. The lack of prolonged treatment with Ab 1e42 on phospholipase C activity also supports the observation on primary cortical neurons demonstrating inhibition of intracellular calcium mobilization by carbachol but not by stimulation of metabotropic glutamate receptor (Huang et al., 2000) .
Numerous studies have failed to find a correlation between the degree of cognitive decline and the number of amyloid plaques in post mortem samples (e.g. Nagy et al., 1995) . However, the cognitive decline in AD has been demonstrated to correlate with post mortem levels of soluble Ab x-40 and x-42 fragments in the cerebral cortex preceding clear tau pathology (Naslund et al., 2000) . On the other hand, a decline in the presynaptic cholinergic marker choline acetyltransferase that correlates with both neuritic plaques and neurofibrillary tangles densities are observed only in advanced stages of the disease (Davis et al., 1999) . This observation speaks for a rather late damage of cholinergic transmission in the course of the disease. In contrast, another recent study reported impaired M1 muscarinic receptor/G-protein coupling that correlates with severity of dementia, thus favoring the contention of an early postsynaptic malfunction of cholinergic transmission (Tsang et al., 2005) . Our results support the view that the increase in soluble Ab fragments results in the attenuation of M1 receptor-mediated signaling that may underlie the early functional deficits and further drive Ab production Nitsch et al., 1992 Nitsch et al., , 2000 Rossner et al., 1997; Caccamo et al., 2006; Medeiros et al., 2011) . Indeed, pharmacological reduction of Ab level reverses behavioral deficits and disorders of piriform cortex field potentials in APPswe/PS1dE9 mice (Cramer et al., 2012) .
In summary, we demonstrate that prolonged in vitro Ab 1e42 treatment of CHO cells expressing M1 muscarinic receptors changes characteristics of agonist binding and attenuates agonist- pellet (open circles) or supernatant (closed circles) prepared from 100 mM A b1e42 stock solution incubated for one day in 10 mM HCl at 37 C by centrifugation at 16 000 g for 15 min. All samples were diluted in supplemented DMEM. The increase in thioflavine fluorescence shown as fold increase (ordinate) over control (DMEM alone) is plotted against A b1e42 concentration in ng per sample (abscissa, logarithmic scale). Points are means from quadruplicates. *, p < 0.05, ***, p < 0.001; significantly different from control by one-way Anova followed by Dunnett's multiple comparison test. C: Electron microscopy analysis of 100 mM Ab 1e42 stock solution shows only sporadic fibrils and no amyloid aggregates. Scale bar 200 nm.
induced activation of phosphatidylinositol signaling. This effect, in line with the notion of the early involvement in pathogenesis of AD, is apparently mediated by low molecular mass Ab 1e42 species. In concert with in vivo results, the treatment does not induce either changes in the expression of major G-proteins, and does not induce oxidative stress or cytotoxicity. These results implicate that the noxious effects of Ab 1e42 on M1 receptor-mediated transmission involve a mechanism that develops within the plasma membrane and impacts receptor/G-protein/phospholipase C interaction. However, detection of specific responsible molecular mechanisms will need further investigation. The attenuation of muscarinic receptor signaling previously reported in a rather early stage of amyloid overproduction in a transgenic mouse model of AD (Machova et al., 2008 (Machova et al., , 2010 
